Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

This publication has 10 references indexed in Scilit:

• Antithrombotic effects of YM‐60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time
  British Journal of Pharmacology, 1998
• YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time
  European Journal of Pharmacology, 1997
• ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD COAGULATION FACTOR Xa IN RAT MODELS OF THROMBOSIS
  Thrombosis Research, 1996
• ‘Silent’ Cerebral Infarction Is Associated With Hypercoagulability, Endothelial Cell Damage, and High Lp(a) Levels in Elderly Japanese
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species
  Blood Coagulation & Fibrinolysis, 1995
• Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes
  Thrombosis Research, 1992
• Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
  Circulation, 1992
• Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT)
  American Journal of Hematology, 1991
• Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatment
  British Journal of Haematology, 1991
• The Characterisation of Thrombus Development in an Improved Model of Arterio-Venous Shunt Thrombosis in the Rat and the Effects of Recombinant Desulphatohirudin (CGP 39393), Heparin, and lloprost
  Thrombosis and Haemostasis, 1991